India, June 30 -- Inside a laboratory at Monash University, miniature replicas of the human brain are revealing secrets that could forever change how we treat childhood brain cancer. These tiny "organoids" - no bigger than a pea - represent a giant leap forward in the fight against medulloblastoma, the most common malignant brain tumour affecting children.
Children's Cancer CoLabhas awarded $455,900 as part of its Next-Generation Therapies Impact Program to this groundbreaking research led by Dr Iman Azimi, recognising its potential to dramatically improve survival rates while sparing young patients from the devastating side effects of current treatments.
When current treatments hurt as much as they help
For children diagnosed with medul...